Literature DB >> 20116688

Associations between renal duplex parameters and adverse cardiovascular events in the elderly: a prospective cohort study.

Jeffrey D Pearce1, Timothy E Craven, Matthew S Edwards, Matthew A Corriere, Teresa A Crutchley, Shawn H Fleming, Kimberley J Hansen.   

Abstract

BACKGROUND: Atherosclerotic renovascular disease is associated with an increased risk of cardiovascular disease (CVD) events. This study examines associations between Doppler-derived parameters from the renal artery and renal parenchyma and all-cause mortality and fatal and nonfatal CVD events in a cohort of elderly Americans. STUDY
DESIGN: Cohort study.
SETTING: A subset of participants from the Cardiovascular Health Study (CHS). Through an ancillary study, 870 (70% recruitment) Forsyth County, NC, CHS participants consented to undergo renal duplex sonography to define the prevalence of renovascular disease in the elderly, resulting in 726 (36% men; mean age, 77 years) technically adequate complete studies included in this investigation. PREDICTOR: Renal duplex sonography-derived Doppler signals from the main renal arteries and renal parenchyma. Spectral analysis from Doppler-shifted frequencies and angle of insonation were used to estimate renal artery peak systolic and end diastolic velocity (both in meters per second). Color Doppler was used to identify the corticomedullary junction. Using a 3-mm Doppler sample, the parenchymal peak systolic and end diastolic frequency shift (both in kilohertz) were obtained. Resistive index was calculated as (1 - [end diastolic frequency shift/peak systolic frequency shift]) using Doppler samples from the hilar arteries of the left or right kidney with the higher main renal artery peak systolic velocity. OUTCOMES & MEASUREMENTS: Proportional hazard regression analysis was used to determine associations between renal duplex sonography-derived Doppler signals and CVD events and all-cause mortality adjusted for accepted cardiovascular risk factors. Index CVD outcomes were defined as coronary events (angina, myocardial infarction, and coronary artery bypass grafting/percutaneous coronary intervention), cerebrovascular events (stroke or transient ischemic attack), and any CVD event (angina, congestive heart failure, myocardial infarction, stroke, transient ischemic attack, and coronary artery bypass grafting [CABG]/percutaneous transluminal coronary intervention [PTCI]).
RESULTS: During follow-up, 221 deaths (31%), 229 CVD events (32%), 122 coronary events (17%), and 92 cerebrovascular events (13%) were observed. Renal duplex sonography-derived Doppler signals from the renal parenchyma were associated independently with all-cause mortality and CVD outcomes. In particular, increased parenchymal end diastolic frequency shift was associated significantly with any CVD event (HR, 0.73; 95% CI, 0.62-0.87; P < 0.001). Marginally significant associations were observed between increases in parenchymal end diastolic frequency shift and decreased risk of death (HR, 0.86; 95% CI, 0.73-1.00; P = 0.06) and decreased risk of cerebrovascular events (HR, 0.78; 95% CI, 0.61-1.01; P = 0.06). Parenchymal end diastolic frequency shift was not significantly predictive of coronary events (HR, 0.84; 95% CI, 0.67-1.06; P = 0.1). LIMITATIONS: CHS participants showed a "healthy cohort" effect that may underestimate the rate of CVD events in the general population.
CONCLUSION: Renal duplex sonographic Doppler signals from the renal parenchyma showed significant associations with subsequent CVD events after controlling for other significant risk factors. In particular, a standard deviation increase in parenchymal end diastolic frequency shift was associated with 27% risk reduction in any CVD event. Copyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20116688      PMCID: PMC2933103          DOI: 10.1053/j.ajkd.2009.10.044

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  33 in total

1.  Renal vascular resistance in progressive systemic sclerosis: evaluation with duplex Doppler ultrasound.

Authors:  K S Aikimbaev; A Canataroğlu; S Ozbek; A Usal
Journal:  Angiology       Date:  2001-10       Impact factor: 3.619

Review 2.  Review. The resistive index in renal Doppler sonography: where do we stand?

Authors:  Mitchell E Tublin; Ronald O Bude; Joel F Platt
Journal:  AJR Am J Roentgenol       Date:  2003-04       Impact factor: 3.959

3.  Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study.

Authors:  Matthew S Edwards; David B Wilson; Timothy E Craven; Jeanette Stafford; Linda F Fried; Tien Y Wong; Ronald Klein; Gregory L Burke; Kimberley J Hansen
Journal:  Am J Kidney Dis       Date:  2005-08       Impact factor: 8.860

4.  Renal resistance index and progression of renal disease.

Authors:  Jörg Radermacher; Sebastian Ellis; Hermann Haller
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

5.  Value of resistive index in patients with clinical diabetic nephropathy.

Authors:  A Sari; H Dinc; A Zibandeh; M Telatar; H R Gümele
Journal:  Invest Radiol       Date:  1999-11       Impact factor: 6.016

6.  Management of ischemic nephropathy: dialysis-free survival after surgical repair.

Authors:  K J Hansen; G S Cherr; T E Craven; S J Motew; J A Travis; J M Wong; P J Levy; B I Freedman; J Ligush; R H Dean
Journal:  J Vasc Surg       Date:  2000-09       Impact factor: 4.268

7.  Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.

Authors:  J Radermacher; A Chavan; J Bleck; A Vitzthum; B Stoess; M J Gebel; M Galanski; K M Koch; H Haller
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

8.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; James M Tielsch; Barbara E K Klein; Larry D Hubbard
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

9.  Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.

Authors:  Graham C Wong; David A Morrow; Sabina Murphy; Nicole Kraimer; Rupal Pai; David James; Debbie H Robertson; Laura A Demopoulos; Peter DiBattiste; Christopher P Cannon; C Michael Gibson
Journal:  Circulation       Date:  2002-07-09       Impact factor: 29.690

10.  Prevalence of renovascular disease in the elderly: a population-based study.

Authors:  Kimberley J Hansen; Matthew S Edwards; Timothy E Craven; Gregory S Cherr; Sharon A Jackson; Richard G Appel; Gregory L Burke; Richard H Dean
Journal:  J Vasc Surg       Date:  2002-09       Impact factor: 4.268

View more
  15 in total

1.  Intrarenal hemodynamic and oxidative stress in patients with obstructive sleep apnea syndrome.

Authors:  L Sardo; P Palange; F Di Mario; B Barbano; A Gigante; M Mordenti; A Steffanina; M Bonini; A Amoroso; F Vaccaro; R Cianci
Journal:  Sleep Breath       Date:  2015-04-01       Impact factor: 2.816

2.  Renal resistive index and mortality in chronic kidney disease.

Authors:  Clarisse Toledo; George Thomas; Jesse D Schold; Susana Arrigain; Heather L Gornik; Joseph V Nally; Sankar D Navaneethan
Journal:  Hypertension       Date:  2015-06-15       Impact factor: 10.190

3.  Significant Correlation between Brachial Pulse Pressure Index and Renal Resistive Index.

Authors:  Meng-Kuang Lee; Po-Chao Hsu; Chun-Yuan Chu; Wen-Hsien Lee; Szu-Chia Chen; Huang-Chi Chen; Ho-Ming Su; Tsung-Hsien Lin; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

Review 4.  Renal resistive index as a marker of vascular damage in cardiovascular diseases.

Authors:  Arkadiusz Lubas; Grzegorz Kade; Stanisław Niemczyk
Journal:  Int Urol Nephrol       Date:  2014-02       Impact factor: 2.370

Review 5.  Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient.

Authors:  Francesca Viazzi; Giovanna Leoncini; Lorenzo E Derchi; Roberto Pontremoli
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

6.  Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.

Authors:  Maciej T Wybraniec; Maria Bożentowicz-Wikarek; Jerzy Chudek; Katarzyna Mizia-Stec
Journal:  Int J Cardiovasc Imaging       Date:  2016-12-19       Impact factor: 2.357

7.  Prognostic significance of the renal resistive index in the primary prevention of type II diabetes.

Authors:  Pascal Delsart; Anne Vambergue; Sandro Ninni; François Machuron; Bénédicte Lelievre; Guillaume Ledieu; Pierre Fontaine; Emilie Merlen; Marie Frimat; François Glowacki; David Montaigne; Claire Mounier-Vehier
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

Review 8.  Renal resistive index in hypertensive patients.

Authors:  Ioannis Andrikou; Costas Tsioufis; Dimitris Konstantinidis; Alexandros Kasiakogias; Kyriakos Dimitriadis; Ioannis Leontsinis; Eirini Andrikou; Elias Sanidas; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-25       Impact factor: 3.738

9.  Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.

Authors:  Naïke Bigé; Pierre Patrick Lévy; Patrice Callard; Jean-Manuel Faintuch; Valérie Chigot; Virginie Jousselin; Pierre Ronco; Jean-Jacques Boffa
Journal:  BMC Nephrol       Date:  2012-10-25       Impact factor: 2.388

10.  Association of Renal Resistive Index, Renal Pulsatility Index, Systemic Hypertension, and Albuminuria with Survival in Dogs with Pituitary-Dependent Hyperadrenocorticism.

Authors:  Hung-Yin Chen; Yu-Hsin Lien; Hui-Pi Huang
Journal:  Int J Endocrinol       Date:  2016-05-31       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.